K2 Principal Fund’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

K2 Principal Fund’s Portfolio CDIOW Stock Details CDIOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-92,500	Closed	-$4.58K	–	278
2022 Q4	$4.58K	Hold	92,500	–	–	﹤0.01%	222
2022 Q3	$12K	Hold	92,500	–	–	﹤0.01%	257
2022 Q2	$15K	Hold	92,500	–	–	﹤0.01%	332
2022 Q1	$18K	Buy	+92,500	New	+$22K	﹤0.01%	293

Other funds holding CDIOW

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ASM

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

K2 Principal Fund's CDIOW Position: Q1 2023 in Review

K2 Principal Fund sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q1 2023, closing a stake of 92,500 shares — an estimated $4.58K sold.

K2 Principal Fund first reported a position in CDIOW in Q1 2022 and held it in 4 quarters. The position peaked at $18K in Q1 2022. 16 funds tracked by Wall St. Rank hold CDIOW as of Q1 2023.

K2 Principal Fund reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q1 2023 after selling out during the quarter.
K2 Principal Fund sold 92,500 Cardio Diagnostics Holdings Inc Warrant shares in Q1 2023, an estimated $4.58K.
K2 Principal Fund first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and held it in 4 quarters.
K2 Principal Fund's Cardio Diagnostics Holdings Inc Warrant position peaked at $18K in Q1 2022.
16 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q1 2023.

Based on K2 Principal Fund's 13F filing for Q1 2023, filed 11 May 2023.